Gastrointestinal complications of nonsteroidal anti-inflammatory drugs: Prophylactic and therapeutic strategies

The American Journal of Medicine

Volumn 96, Issue 3, 1994, Pages 274-281

  Hollander, Daniel ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; MISOPROSTOL; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PROSTAGLANDIN; SUCRALFATE;

ALCOHOL CONSUMPTION; CELL PROTECTION; CIGARETTE SMOKING; DIAGNOSTIC APPROACH ROUTE; DIGESTIVE SYSTEM PERFORATION; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL HEMORRHAGE; HELICOBACTER PYLORI; HUMAN; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; RISK FACTOR; STOMACH ULCER;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; GASTROINTESTINAL DISEASES; HUMAN; RISK FACTORS;

EID: 0028230670     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9343(94)90153-8     Document Type: Review

References (56)

1. Utilization of nonsteroidal anti-inflammatory drugs
2. Prevalence of mucosal lesions in the stomach and duodeum due to chronic use of NSAIDs in patients with RA or OA, and interim report on prevention by misoprostol of diclofenac-associated lesions
3. Misoprostol heals gastroduodenal injury in patients with rheumatoid arthritis receiving aspirin
4. Peptic ulcer in rheumatoid arthritis.
5. Contrasting presentation and findings between patients with rheumatic complaints taking nonsteroidal anti-inflammatory drugs with a general population referred for endoscopy
6. NSAIDs with or without prednisone: bad news for the gut mucosa
7. Upper gastrointestinal findings and faecal occult blood in patients with rheumatic diseases taking nonsteroidal anti-inflammatory drugs
8. Effect of anti-inflammatory drug administration in patients with rheumatoid arthritis: an endoscopic assessment
9. Non-steroidal anti-inflammatory drugs and hospitalization for gastroesophageal bleeding in the elderly
10. Nonsteroidal anti-inflammatory drug use increased risk for peptic ulcer disease in elderly persons
11. Gastroscopic evaluation of anti-inflammatory agents
12. Incidence of gastric lesions in patients with rheumatic disease on chronic aspirin therapy
13. Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration
14. Direct medical costs of disease and gastrointestinal side effects during treatment for arthritis
15. Toward an epidemiology of gastropathy associated with nonsteroidal anti-inflammatory drug use
16. Mechanisms of Gastrointestinal Toxicity of Nonsteroidal Anti-Inflammatory Drugs
17. Gastric mucosal lesions produced by intravenous infusion of aspirin in cats
18. A double-blind placebo controlled endoscopic study comparing the mucosal injury seen with orally and parenterally administered nonsteroidal analgesic ketorolac tromethamine at therapeutic and supratherapeutic doses
19. Gastric microvascular endothelium: a major target for aspirin-induced injury and arachidonic acid protection
20. The Protective and Therapeutic Mechanisms of Sucralfate
21. Double blind controlled study on the effect of sucralfate on gastric prostaglandin formation and microbleeding in normal and aspirin treated man
22. Prostaglandin but not cimetidine reduces spontaneous degeneration of isolated gastric gland cells
23. Intestinal absorption of aspirin influence of pH, taurocholate, ascorbate and ethanol
24. The mechanisms of action of nonsteroidal anti-inflammatory drugs
25. The role of essential fatty acids in gastric and duodenal protection and ulcer therapy
26. Prevention of NSAID-induced gastric ulcer with misoprostol: multicenter, double-blind, placebo controlled trial
27. Chemotactic factor-induced generation of superoxide radicals by human neutrophils: effect of metabolic inhibitors and anti-inflammatory drugs
28. Some nonsteroidal anti-inflammatory drugs inhibit the generation of superoxide anions by activated polymorphs by blocking ligand-receptor interactions
29. The action of NSAIDS
30. CSM Update: Non-steroidal anti-inflammatory drugs and serious gastrointestinal adverse reactions--1
31. Epidemiologic evidence on the association between peptic ulceration and anti-inflammatory drug use
32. Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs
33. Relation of upper gastrointestinal bleeding to nonsteroidal anti-inflammatory drugs and aspirin: a case-control study
34. Long-term nonsteroidal anti-inflammatory drug use and Helicobacter pylori infection
35. Is Compylobacter pylori (CP) prevalence lower in gastric ulcers (GU's) because of nonsteroidal anti-inflammatory drug (NSAID) use
36. Chronic nonsteroidal anti-inflammatory drug use and gastroduodenal injury: the role of Helicobacter pylori
37. Enteroscopic diagnosis of small bowel ulceration in patients receiving nonsteroidal anti-inflammatory drugs
38. Intestinal perforation associated with osmotic slow release indomethacin capsules
39. Enterohepatic circulation of indomethacin and its role in intestinal irritation
40. Effect of 16, 16-dimethyl PGE2 and indomethacin on bile acid-induced intestinal injury and restitution in rats
41. Regulation of polyethylene glycol 400 intestinal permeability by endogenous and exogenous prostanoids
42. Importance of local versus systemic effects of nonsteroidal anti-inflammatory drugs in increasing small intestinal permeability in man
43. Intestinal mucosal permeability and rheumatologic diseases
44. Misoprostol Compared with Sucralfate in the Prevention of Nonsteroidal Anti-inflammatory Drug-induced Gastric Ulcer
45. Duodenal and gastric ulcer prevention with misoprostol in arthritis patients taking NSAIDs
46. Prevention of gastroduodenal damage induced by nonsteroidal anti-inflammatory drugs: controlled trial with ranitidine
47. Effect of ranitidine on gastroduodenal mucosal damage induced by nonsteroidal anti-inflammatory drugs
48. Double-blind comparative study of the efficacy and safety of misoprostol and ranitidine in the prevention of NSAID-induced gastric ulcers and upper GI symptoms: preliminary findings
49. Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer
50. Resistance to medical therapy of gastric ulcers in rheumatic disease patients taking aspirin: a double-blind study with cimetidine and follow-up
51. Ranitidine in the treatment of nonsteroidal anti-inflammatory drug associated gastric and duodenal ulcers
52. Sucrose, a novel, site specific permeability marker for gastric damage
53. Sucrose: a novel permeability marker for gastroduodenal disease
54. Permeability in Crohn's disease—altered barrier functions in healthy relatives